Rosuvastatin calcium and Peppermint drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rosuvastatin calcium (rosuvastatin calcium) and Peppermint (peppermint). Common drug interactions include constipation among females and nasopharyngitis among males.

The phase IV clinical study analyzes what interactions people have when they take Rosuvastatin calcium and Peppermint. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Rosuvastatin calcium?

Rosuvastatin calcium has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 25,353 Rosuvastatin calcium users. Check the latest studies of Rosuvastatin calcium.

What is Peppermint?

Peppermint has active ingredients of peppermint. eHealthMe is studying from 1,327 Peppermint users. Check the latest studies of Peppermint.



On Jul, 13, 2026

11 people who take Rosuvastatin calcium and Peppermint together, and have interactions are studied.

Rosuvastatin calcium and Peppermint drug interactions.

What are the common drug interactions of Rosuvastatin Calcium and Peppermint, by gender? *:

female:

  1. Constipation
  2. Diarrhoea
  3. Arthralgia (joint pain)
  4. Bacterial infection
  5. Blood sodium decreased
  6. Exostosis (formation of new bone on the surface of a bone)
  7. Fall
  8. Fatigue (feeling of tiredness)
  9. Foot deformity (functional disability of foot)
  10. Herpes zoster

male:

  1. Nasopharyngitis (inflammation of the nasopharynx)
  2. Obstructive airways disorder (a progressive disease that makes it hard to breathe)
  3. Cough
  4. Dysphonia (speech disorder attributable to a disorder of phonation)
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  7. Exostosis (formation of new bone on the surface of a bone)
  8. Myoglobin blood increased (presence of myoglobin in blood increased)
  9. Obstructive sleep apnoea syndrome (frequent pauses in breathing during sleep usually accompanied by loud snoring)
  10. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)

What are the common drug interactions of Rosuvastatin Calcium and Peppermint, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Nasopharyngitis (inflammation of the nasopharynx)
  2. Obstructive airways disorder (a progressive disease that makes it hard to breathe)
  3. Cough
  4. Dysphonia (speech disorder attributable to a disorder of phonation)
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  7. Exostosis (formation of new bone on the surface of a bone)
  8. Myoglobin blood increased (presence of myoglobin in blood increased)
  9. Obstructive sleep apnoea syndrome (frequent pauses in breathing during sleep usually accompanied by loud snoring)
  10. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)

What are the existing conditions these people have? *

  1. Secretion Discharge: 4 people, 36.36%
  2. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung): 4 people, 36.36%
  3. Asthma: 4 people, 36.36%
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 36.36%
  5. Nasopharyngitis (inflammation of the nasopharynx): 4 people, 36.36%
  6. Chest Pain: 4 people, 36.36%
  7. Cough: 4 people, 36.36%
  8. Hoarseness Or Changing Voice: 4 people, 36.36%
  9. Dyspnea (difficult or laboured breathing): 4 people, 36.36%
  10. Immunodeficiency Common Variable: 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Rosuvastatin calcium and Peppermint?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rosuvastatin calcium and Peppermint:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rosuvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Peppermint:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rosuvastatin calcium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Peppermint and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rosuvastatin calcium and peppermint (the active ingredients of Rosuvastatin calcium and Peppermint, respectively), and Rosuvastatin calcium and Peppermint (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: